![](https://cdn.sanity.io/images/0vv8moc6/mhe/664ce9788a94261daa26a44d722e031bdea67c81-640x380.png?fit=crop&auto=format)
Modeling Study Projects Vitrakvi (Larotrectinib) to Extend Life Expectancy in Certain Lung and Thyroid Cancers
A recent study published in the Journal of Managed Care & Specialty Pharmacy analyzed the long-term effectiveness of Vitrakvi (larotrectinib) compared with immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer (NSCLC) and …